The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 06, 2026

Filed:

May. 10, 2021
Applicant:

Neurolign Usa, Llc, Pittsburgh, PA (US);

Inventors:

John Howison Schroeder, Pittsburgh, PA (US);

Robin C. Ashmore, Pittsburgh, PA (US);

Alexander D. Kiderman, Pittsburgh, PA (US);

Peter Charles Doyle, Sherborn, MA (US);

Assignee:

SPRYSON INC., Middletown, DE (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61B 3/113 (2006.01); A61B 5/11 (2006.01); A61K 31/155 (2006.01); A61K 31/198 (2006.01); A61K 38/27 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61B 5/4848 (2013.01); A61B 3/113 (2013.01); A61B 5/11 (2013.01); A61B 5/4064 (2013.01); A61K 31/155 (2013.01); A61K 31/198 (2013.01); A61K 38/27 (2013.01); A61K 45/06 (2013.01); A61B 2560/02 (2013.01);
Abstract

A Neurological Rehabilitation method utilizing oculomotor, visual and/or vestibular rehabilitation tasks on subjects with pharmacologically induced neuroplasticity comprising the steps of Inducing neuroplasticity in a subject through administering of a neuroplasticity medicament; Providing a oculomotor, visual and vestibular rehabilitation task platform configured to supply visual targets to a subject for oculomotor, visual and vestibular rehabilitation tasks and track and record eye movement of the subject during oculomotor, visual and vestibular rehabilitation tasks; Performing oculomotor, visual and/or vestibular rehabilitation tasks on the platform with subjects during periods of pharmacologically induced neuroplasticity. The neuroplasticity medicament generally is comprising at least one of an antidepressant, a Brain Derived Neuro trophic factor enhancer, a steroid, a psychedelic, valproic acid, NDRI's, lithium carbonate, Metformin, N-Acetylcystine, and Human Growth Hormone.


Find Patent Forward Citations

Loading…